Franck Ceppa

1.3k total citations
52 papers, 359 citations indexed

About

Franck Ceppa is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Franck Ceppa has authored 52 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Franck Ceppa's work include Cholinesterase and Neurodegenerative Diseases (9 papers), Pesticide Exposure and Toxicity (5 papers) and Pleural and Pulmonary Diseases (5 papers). Franck Ceppa is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (9 papers), Pesticide Exposure and Toxicity (5 papers) and Pleural and Pulmonary Diseases (5 papers). Franck Ceppa collaborates with scholars based in France, Russia and United States. Franck Ceppa's co-authors include P. Burnat, Hervé Delacour, H. Mayaudon, Olivier Dupuy, Thierry Gidenne, B. Bauduceau, Sofya V. Lushchekina, Lawrence M. Schopfer, Oksana Lockridge and Patrick Masson and has published in prestigious journals such as PLoS ONE, Biochemical Pharmacology and Clinical Biochemistry.

In The Last Decade

Franck Ceppa

47 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franck Ceppa France 10 73 70 67 57 56 52 359
Cormac Kennedy Ireland 10 55 0.8× 70 1.0× 45 0.7× 58 1.0× 36 0.6× 49 353
Bhavna Solanki United States 10 76 1.0× 60 0.9× 42 0.6× 77 1.4× 20 0.4× 28 339
Parloop Bhatt India 13 51 0.7× 105 1.5× 47 0.7× 116 2.0× 53 0.9× 33 406
Bharti Chogtu India 12 34 0.5× 55 0.8× 18 0.3× 49 0.9× 91 1.6× 62 375
R. Bonn Germany 10 48 0.7× 30 0.4× 85 1.3× 59 1.0× 52 0.9× 34 326
Ahmad S. Azhar Saudi Arabia 14 33 0.5× 58 0.8× 76 1.1× 67 1.2× 30 0.5× 39 429
Е. В. Ших Russia 8 31 0.4× 33 0.5× 31 0.5× 58 1.0× 42 0.8× 142 344
Pedro L. Tornel Spain 12 90 1.2× 220 3.1× 322 4.8× 81 1.4× 75 1.3× 19 650
Richard Andraws United States 6 58 0.8× 65 0.9× 124 1.9× 88 1.5× 78 1.4× 6 404
Isabel Fort-Gallifa Spain 14 44 0.6× 71 1.0× 56 0.8× 86 1.5× 45 0.8× 38 499

Countries citing papers authored by Franck Ceppa

Since Specialization
Citations

This map shows the geographic impact of Franck Ceppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Ceppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Ceppa more than expected).

Fields of papers citing papers by Franck Ceppa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franck Ceppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Ceppa. The network helps show where Franck Ceppa may publish in the future.

Co-authorship network of co-authors of Franck Ceppa

This figure shows the co-authorship network connecting the top 25 collaborators of Franck Ceppa. A scholar is included among the top collaborators of Franck Ceppa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franck Ceppa. Franck Ceppa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brazzolotto, Xavier, et al.. (2020). Characterization of four BCHE mutations associated with prolonged effect of suxamethonium. The Pharmacogenomics Journal. 21(2). 165–173. 4 indexed citations
2.
Dubost, Clément, et al.. (2018). Myoglobin: still a useful biomarker in 2017?. Annales de biologie clinique. 76(2). 137–141. 6 indexed citations
3.
Delacour, Hervé, et al.. (2017). Diagnosis of genetic predisposition for lactose intolerance by high resolution melting analysis. Annales de biologie clinique. 75(1). 67–74. 4 indexed citations
4.
Ceppa, Franck, et al.. (2016). Curarisation prolongée liée à un déficit en butyrylcholinestérase. Archives de Pédiatrie. 23(5). 497–500. 1 indexed citations
5.
Delacour, Hervé, et al.. (2016). Butyrylcholinesterase deficiency. Annales de biologie clinique. 74(3). 279–285. 17 indexed citations
6.
Ceppa, Franck, et al.. (2014). Rapid detection of BCHE atypical variant (p.Asp70Gly) by high resolution melting curve analysis. Annales de biologie clinique. 72(5). 543–548. 2 indexed citations
7.
Delacour, Hervé, Sofya V. Lushchekina, Franck Ceppa, et al.. (2014). Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), “silent” with mivacurium. Biochemical Pharmacology. 92(3). 476–483. 22 indexed citations
8.
Delacour, Hervé, et al.. (2012). Hereditary Neuropathy with Liability to Pressure Palsies Occurring During Military Training. Journal of the Royal Army Medical Corps. 158(1). 47–49. 5 indexed citations
9.
Delacour, Hervé, et al.. (2009). Génotype HLA-B*5701 et hypersensibilité à l’abacavir. Pathologie Biologie. 58(6). e95–e100. 1 indexed citations
10.
Ceppa, Franck, et al.. (2007). Pancréatite aiguë survenant après la prise de celecoxib. Gastroentérologie Clinique et Biologique. 31(8-9). 668–669. 5 indexed citations
11.
Bauduceau, B., H. Mayaudon, P. Burnat, et al.. (2007). Should we have more definitions of metabolic syndrome or simply take waist measurement?. Diabetes & Metabolism. 33(5). 333–339. 12 indexed citations
12.
Bordier, L., et al.. (2007). Prise en charge du syndrome de Nelson : données actuelles. La Revue de Médecine Interne. 28(11). 766–769. 4 indexed citations
13.
Bordier, L., P. Burnat, Franck Ceppa, et al.. (2006). Inefficacité des bandelettes urinaires dans la recherche de néphropathie incipiens chez les diabétiques. La Presse Médicale. 35(7-8). 1117–1121. 2 indexed citations
14.
Bauduceau, B., F. Baigts, L. Bordier, et al.. (2005). Epidemiology of the metabolic syndrome in 2045 French military personnel (EPIMIL study). Diabetes & Metabolism. 31(4). 353–359. 37 indexed citations
15.
Ceppa, Franck, et al.. (2005). Curarisation prolongée à la succinylcholine liée à un variant silencieux de la cholinestérase plasmatique. Annales Françaises d Anesthésie et de Réanimation. 24(4). 425–427. 7 indexed citations
16.
Gidenne, Thierry, et al.. (2004). Analytical performance of the Albumin Cobalt Binding (ACB®) test on the Cobas MIRA® Plus analyzer. Clinical Chemistry and Laboratory Medicine (CCLM). 42(4). 455–61. 56 indexed citations
17.
Gidenne, Thierry, et al.. (2003). [Methemalbuminnemia after massive hemolysis during blackwater fever].. PubMed. 61(3). 332–6. 1 indexed citations
18.
Ceppa, Franck, et al.. (2002). Rapid Identification of Atypical Variant of Plasma Butyrylcholinesterase by PCR. Clinical Chemistry and Laboratory Medicine (CCLM). 40(8). 799–801. 8 indexed citations
19.
Ceppa, Franck, et al.. (2001). Intoxication by ethylene glycol. Annales de biologie clinique. 59(5). 2 indexed citations
20.
Ceppa, Franck, et al.. (2000). High-performance liquid chromatographic determination of cotinine in urine in isocratic mode. Journal of Chromatography B Biomedical Sciences and Applications. 746(2). 115–122. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026